The aberrant upregulation of DLGAP1-AS2 was further validated in four additional CRC cohorts (GSE32323, GSE8671, GSE18105 and GSE22598; Fig. 1B and Fig.S1A). The gene discussed is DLGAP1; the disease is colorectal carcinoma.